Pancreatic Cancer Cells Exploit Oxygen Deprivation and Nutrient Profiles to Build Resistance Against Ferroptosis Cell Death

Ludwig Institute researchers discover how oxygen deficiency and tumor fluid work together to protect pancreatic cancer cells from ferroptosis.

By: AXL Media

Published: Apr 3, 2026, 6:56 AM EDT

Source: Information for this report was sourced from Ludwig Institute for Cancer Research

The Paradox of KRAS Mutations and Ferroptosis Resistance

While many cancers driven by KRAS mutations are naturally susceptible to ferroptosis—a form of iron-dependent regulated cell death—pancreatic ductal adenocarcinoma (PDAC) has long remained a clinical exception. Despite more than 95% of these tumors harboring such mutations, they exhibit a notorious intractability that has puzzled oncologists for years. New research led by Chi Van Dang and Maimon Hubbi at the Ludwig Institute for Cancer Research has finally decoded this mystery. The team discovered that the unique biological landscape of pancreatic tumors creates a protective shield that prevents the cascading lipid oxidation necessary for membrane disintegration. This findings offer a clearer understanding of why standard ferroptosis-inducing therapies often fail in advanced pancreatic cases.

The Role of Hypoxia and the Fibrous Tumor Sheath

Pancreatic tumors are characterized by a dense, nearly impenetrable sheath of fibrous tissue and an exceptionally sparse supply of blood vessels. This unique structural composition creates a tumor microenvironment (TME) that is severely starved of oxygen, a condition known as hypoxia. To survive in these suffocating conditions, PDAC cells express high levels of Hypoxia-Inducible Factor-2 (HIF-2), a cellular sensor designed to manage survival during oxygen deprivation. While high levels of HIF-2 are known to make other cancers, such as kidney cancer, more vulnerable to cell death, the researchers found that in the specific context of the pancreas, this protein acts as a primary coordinator of resistance.

Metabolic Synergy in the Interstitial Fluid

To accurately replicate the conditions inside a human tumor, the research team utilized a specialized culture medium that mimics the interstitial fluid found between PDAC cells. When hypoxic cells were grown in this nutrient-specific environment and exposed to ferroptosis-inducing compounds like erastin, the results were definitive. The combination of low oxygen and the unique metabolic profile of the pancreatic fluid almost entirely protected the cancer cells from death. According to Maimon Hubbi, this synergy reveals that the environmental context of the tumor is just as critical as its genetic makeup in determining therapeutic success. This suggests that future treatments must account for the fluid chemistry surroun...